| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |